DUBLIN--(BUSINESS WIRE)--The "Global Non-Invasive BGI prenatal test Market: Focus on Method, Test, Platform, End User, Application and Country Analysis and Forecast, 2020-2031" report has been added to ResearchAn***rkets.com's offering.
The global NIPT market was valued at $2.52 billion in 2020 and is expected to reach $12.61 billion by 2031, registering a CAGR of 15.79% during the forecast period 2021-2031.
Market Dynamics
Growth Drivers
Increased Emphasis on Early ***ection and Prevention
Availability of Advanced Screening Technologies
Increasing Consumer Demand
Shifting of Reimbursement Policies Toward More Genetics Coverage
High Incidence Rate of Down's Syndrome
Rising Average Maternal Age
Increasing Prevalence of Genetic and Congenital Disorders
Challenges
Stringent Regulatory Guidelines and Ethical Hurdles
Limitations of NIPT
Lack of Awareness Among Consumers
Alternative Screening and Testing Methods
Opportunities
Capitalizing on the Potential Presented by the Emerging Markets in Asia
Availability of Direct-to-Consumer Tests
Focus on Pre-Implantation Genetic Diagnosis
Market Segmentation
By Test - Panorama and Vistara; MaterniT GENOME, MaterniT 21 PLUS, informaSeq, Verifi and Verifi Plus Prenatal Tests; Harmony Test; NIFTY Test and NIFTY Test Pro; QNatal Advanced; PrenaTest, GeneSafe, and PrenatalSAFE; Bambni Test; IONA and Sage; and Others. |
Home
